Anzahl der Einträge: 11.
Weller, Johannes ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Schaub, Christina,
Potthoff, Anna-Laura,
Steinbach, Joachim P.,
Schlegel, Uwe,
Sabel, Michael ![ORCID 0009-0000-1485-7820](/images/orcid_16x16.gif)
,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Seidel, Clemens,
Krex, Dietmar,
Goldbrunner, Roland,
Pietsch, Torsten,
Tzaridis, Theophilos,
Zeyen, Thomas,
Borger, Valeri,
Güresir, Erdem,
Vatter, Hartmut,
Herrlinger, Ulrich und
Schneider, Matthias
(2022)
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
Journal of Neuro-Oncology 159 (1), S. 95-101.
Zeyen, Thomas,
Potthoff, Anna-Laura,
Nemeth, Robert,
Heiland, Dieter H.,
Burger, Michael C.,
Steinbach, Joachim P.,
Hau, Peter,
Tabatabai, Ghazaleh,
Glas, Martin,
Schlegel, Uwe,
Grauer, Oliver,
Krex, Dietmar,
Schnell, Oliver,
Goldbrunner, Roland,
Sabel, Michael ![ORCID 0009-0000-1485-7820](/images/orcid_16x16.gif)
,
Thon, Niklas,
Delev, Daniel,
Clusmann, Hans,
Seidel, Clemens,
Güresir, Erdem,
Schmid, Matthias ![ORCID 0000-0002-0788-0317](/images/orcid_16x16.gif)
,
Schuss, Patrick ![ORCID 0000-0002-5806-2576](/images/orcid_16x16.gif)
,
Giordano, Frank A.,
Radbruch, Alexander,
Becker, Albert,
Weller, Johannes,
Schaub, Christina,
Vatter, Hartmut,
Schilling, Judith,
Winkler, Frank ![ORCID 0000-0003-4892-6104](/images/orcid_16x16.gif)
,
Herrlinger, Ulrich und
Schneider, Matthias
(2022)
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.
Trials 23 (1).
Volltext nicht vorhanden.
Tzaridis, Theophilos ![ORCID 0000-0001-9651-1144](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Weller, Johannes,
Steinbach, Joachim‐Peter,
Schlegel, Uwe,
Seidel, Sabine,
Sabel, Michael,
Hau, Peter,
Seidel, Clemens,
Krex, Dietmar,
Goldbrunner, Roland,
Tonn, Jörg‐Christian,
Grauer, Oliver,
Kebir, Sied,
Schneider, Matthias,
Schaub, Christina,
Vatter, Hartmut,
Coch, Christoph,
Glas, Martin,
Fimmers, Rolf,
Pietsch, Torsten,
Reifenberger, Guido,
Herrlinger, Ulrich und
Felsberg, Jörg
(2021)
MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial.
International Journal of Cancer 148 (7), S. 1695-1707.
Volltext nicht vorhanden.
Kamp, Marcel A.,
Malzkorn, Bastian,
von Sass, Christiane,
DiMeco, Francesco,
Hadjipanayis, Constantinos G.,
Senft, Christian ![ORCID 0000-0003-1288-6913](/images/orcid_16x16.gif)
,
Rapp, Marion,
Gepfner-Tuma, Irina,
Fountas, Konstantinos,
Krieg, Sandro M. ![ORCID 0000-0003-4050-1531](/images/orcid_16x16.gif)
,
Neukirchen, Martin,
Florian, Ioan Ștefan,
Schnell, Oliver,
Mijderwijk, Hendrik-Jan ![ORCID 0000-0002-9516-8257](/images/orcid_16x16.gif)
,
Perin, Alessandro ![ORCID 0000-0002-6697-9835](/images/orcid_16x16.gif)
,
Baumgarten, Peter,
van Lieshout, Jasper H.,
Thon, Niklas,
Renovanz, Miriam,
Kahlert, Ulf,
Spoor, Jochem K. H.,
Hänggi, Daniel,
McLean, Aaron Lawson,
Mäurer, Matthias,
Sarrubbo, Silvio,
Freyschlag, Christian F. ![ORCID 0000-0002-8228-8217](/images/orcid_16x16.gif)
,
Schmidt, Nils O. ![ORCID 0000-0001-6910-8843](/images/orcid_16x16.gif)
,
Vergani, Francesco,
Jungk, Christine,
Stein, Marco,
Forster, Marie-Therese,
Weinberg, Jeffrey S. ![ORCID 0000-0001-5587-6673](/images/orcid_16x16.gif)
,
Sinclair, John,
Belykh, Evgenii,
Bello, Lorenzo ![ORCID 0000-0001-6797-7105](/images/orcid_16x16.gif)
,
Mandonnet, Emmanuel,
Moiyadi, Aliasgar und
Sabel, Michael
(2021)
Proposed definition of competencies for surgical neuro-oncology training.
Journal of Neuro-Oncology 153 (1), S. 121-131.
Volltext nicht vorhanden.
Kebir, Sied,
Schaub, Christina,
Junold, Nina,
Hattingen, Elke ![ORCID 0000-0002-8392-9004](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Steinbach, Joachim P.,
Weyerbrock, Astrid,
Hau, Peter,
Goldbrunner, Roland,
Galldiks, Norbert ![ORCID 0000-0002-2485-1796](/images/orcid_16x16.gif)
,
Weller, Johannes ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Mack, Frederic,
Tzaridis, Theophilos,
Bähr, Oliver,
Seidel, Clemens,
Schlegel, Uwe,
Schmidt-Graf, Friederike,
Rohde, Veit,
Borchers, Christian,
Tabatabai, Ghazaleh ![ORCID 0000-0002-3542-8782](/images/orcid_16x16.gif)
,
Hänel, Mathias,
Sabel, Michael,
Gerlach, Rüdiger,
Krex, Dietmar,
Belka, Claus,
Vatter, Hartmut,
Proescholdt, Martin,
Glas, Martin und
Herrlinger, Ulrich
(2019)
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Journal of Neuro-Oncology 144 (3), S. 501-509.
Volltext nicht vorhanden.
Herrlinger, Ulrich,
Tzaridis, Theophilos,
Mack, Frederic,
Steinbach, Joachim Peter,
Schlegel, Uwe,
Sabel, Michael,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Kortmann, Rolf-Dieter,
Krex, Dietmar,
Grauer, Oliver,
Goldbrunner, Roland,
Schnell, Oliver,
Bähr, Oliver,
Uhl, Martin,
Seidel, Clemens,
Tabatabai, Ghazaleh ![ORCID 0000-0002-3542-8782](/images/orcid_16x16.gif)
,
Kowalski, Thomas,
Ringel, Florian,
Schmidt-Graf, Friederike,
Suchorska, Bogdana,
Brehmer, Stefanie,
Weyerbrock, Astrid,
Renovanz, Miriam,
Bullinger, Lars,
Galldiks, Norbert ![ORCID 0000-0002-2485-1796](/images/orcid_16x16.gif)
,
Vajkoczy, Peter,
Misch, Martin,
Vatter, Hartmut,
Stuplich, Moritz,
Schäfer, Niklas,
Kebir, Sied,
Weller, Johannes ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Schaub, Christina,
Stummer, Walter,
Tonn, Jörg-Christian,
Simon, Matthias,
Keil, Vera C.,
Nelles, Michael,
Urbach, Horst,
Coenen, Martin,
Wick, Wolfgang ![ORCID 0000-0002-6171-634X](/images/orcid_16x16.gif)
,
Weller, Michael ![ORCID 0000-0001-5818-5392](/images/orcid_16x16.gif)
,
Fimmers, Rolf,
Schmid, Matthias ![ORCID 0000-0002-0788-0317](/images/orcid_16x16.gif)
,
Hattingen, Elke ![ORCID 0000-0002-8392-9004](/images/orcid_16x16.gif)
,
Pietsch, Torsten,
Coch, Christoph und
Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
Schaub, Christina,
Kebir, Sied,
Junold, Nina,
Hattingen, Elke ![ORCID 0000-0002-8392-9004](/images/orcid_16x16.gif)
,
Schäfer, Niklas,
Steinbach, Joachim P.,
Weyerbrock, Astrid,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Goldbrunner, Roland,
Niessen, Michael,
Mack, Frederic,
Stuplich, Moritz,
Tzaridis, Theophilos,
Bähr, Oliver,
Kortmann, Rolf-Dieter,
Schlegel, Uwe,
Schmidt-Graf, Friederike,
Rohde, Veit,
Braun, Christian,
Hänel, Mathias,
Sabel, Michael,
Gerlach, Rüdiger,
Krex, Dietmar,
Belka, Claus,
Vatter, Hartmut,
Proescholdt, Martin,
Herrlinger, Ulrich und
Glas, Martin
(2018)
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Journal of Cancer Research and Clinical Oncology 144 (8), S. 1581-1589.
Volltext nicht vorhanden.
Schäfer, Niklas,
Proescholdt, Martin,
Steinbach, Joachim P,
Weyerbrock, Astrid,
Hau, Peter ![ORCID 0000-0003-3894-5053](/images/orcid_16x16.gif)
,
Grauer, Oliver,
Goldbrunner, Roland,
Friedrich, Franziska,
Rohde, Veit,
Ringel, Florian,
Schlegel, Uwe,
Sabel, Michael,
Ronellenfitsch, Michael W,
Uhl, Martin,
Grau, Stefan,
Hänel, Mathias,
Schnell, Oliver,
Krex, Dietmar,
Vajkoczy, Peter,
Tabatabai, Ghazaleh,
Mack, Frederic,
Schaub, Christina,
Tzaridis, Theophilos,
Nießen, Michael,
Kebir, Sied,
Leutgeb, Barbara,
Urbach, Horst,
Belka, Claus,
Stummer, Walter,
Glas, Martin und
Herrlinger, Ulrich
(2017)
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
Neuro-Oncology 20 (7), S. 975-985.
Volltext nicht vorhanden.
Herrlinger, Ulrich,
Schäfer, Niklas,
Steinbach, Joachim P. ![ORCID 0000-0002-1708-6440](/images/orcid_16x16.gif)
,
Weyerbrock, Astrid,
Hau, Peter,
Goldbrunner, Roland,
Friedrich, Franziska,
Rohde, Veit,
Ringel, Florian,
Schlegel, Uwe,
Sabel, Michael,
Ronellenfitsch, Michael W. ![ORCID 0000-0002-1402-6290](/images/orcid_16x16.gif)
,
Uhl, Martin,
Maciaczyk, Jaroslaw,
Grau, Stefan,
Schnell, Oliver,
Hänel, Mathias,
Krex, Dietmar,
Vajkoczy, Peter,
Gerlach, Rüdiger,
Kortmann, Rolf-Dieter,
Mehdorn, Maximilian,
Tüttenberg, Jochen,
Mayer-Steinacker, Regine,
Fietkau, Rainer,
Brehmer, Stefanie,
Mack, Frederic,
Stuplich, Moritz,
Kebir, Sied,
Kohnen, Ralf,
Dunkl, Elmar,
Leutgeb, Barbara,
Proescholdt, Martin,
Pietsch, Torsten,
Urbach, Horst,
Belka, Claus,
Stummer, Walter und
Glas, Martin
(2016)
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
Journal of Clinical Oncology 34 (14), S. 1611-1619.
Volltext nicht vorhanden.
Wick, Wolfgang,
Platten, Michael,
Meisner, Christoph,
Felsberg, Jörg,
Tabatabai, Ghazaleh,
Simon, Matthias,
Nikkhah, Guido,
Papsdorf, Kirsten,
Steinbach, Joachim P.,
Sabel, Michael,
Combs, Stephanie E.,
Vesper, Jan,
Braun, Christian,
Meixensberger, Jürgen,
Ketter, Ralf,
Mayer-Steinacker, Regine,
Reifenberger, Guido und
Weller, Michael
(2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
The lancet oncology 13 (7), S. 707-715.
Volltext nicht vorhanden.
Floeth, Frank W.,
Pauleit, Dirk,
Sabel, Michael,
Stoffels, Gabriele,
Reifenberger, Guido,
Riemenschneider, Markus J.,
Jansen, Paul,
Coenen, Heinz H.,
Steiger, Hans-Jakob und
Langen, Karl-Josef
(2007)
Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.
Journal of nuclear medicine : official publication 48 (4), S. 519-527.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Sat Aug 17 02:19:26 2024 CEST.